Dash Bio, Inc. funding
Dash Bio, Inc., a health care company based in Boston, MA (founded 2024), filed a Form D with the SEC on July 14, 2026 and reported $30M raised.
Amount raised$30M
Offering size$30M
Filed with the SECJuly 14, 2026
First saleJune 15, 2026
IndustryOther Health Care
SecuritiesEquity
LocationBoston, MA
Founded2024
Entity typeCorporation
Investors so far9
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jul 14
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$22.8M · Sep 16Other Health CareXact Bio, Inc.$10M · Sep 28BiotechnologyCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care